The medicinal cannabis sector risks repeating the mistakes that fuelled the opioid and benzodiazepine crises, a […]
Medicinal Cannabis Industry Must Learn From Benzo and Opioid Failures, Addiction Expert Says
The Cannabis Observer
·
FOUNDING MEMBERS
First 100 readers lock in 50% off for life
Sector coverage written for operators, not tourists. Reserve founding-member pricing before launch.
- Weekday briefings on regulation, access schemes, and the companies shaping the market
- Full archive and weekly deep-dives once premium goes live
- 50% off the launch price, locked in for as long as your subscription stays active
Join 87 readers already on the waitlist
addiction medicine
ADHD stimulants
AMCA
benzodiazepines
Dr Peter Grinspoon
Nick Lintzeris
opioid crisis
prescribing thresholds
UIC Conference
Related Articles
